Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00718328 · ClinicalTrials.gov registry record · Phase 2
Simvastatin For Intracerebral Hemorrhage Study
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00718328: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT00718328 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00718328, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Study Objective: To analyze if statins are effective in ameliorating perihematomal edema evolution thereby reducing mortality and improving functional outcomes following spontaneous intracerebral hemorrhage (ICH).
Interventions
- DRUG Placebo
- DRUG Simvastatin 80 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00718328
The ClinicalTrials.gov registry entry for NCT00718328 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00718328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00718328 about?
NCT00718328 is a clinical study titled "Simvastatin For Intracerebral Hemorrhage Study". Study Objective: To analyze if statins are effective in ameliorating perihematomal edema evolution thereby reducing mortality and improving functional outcomes following spontaneous intracerebral hemorrhage (ICH).
What is the current status of trial NCT00718328?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00718328?
The interventions under investigation include: Placebo (DRUG), Simvastatin 80 mg (DRUG).
Who is sponsoring clinical trial NCT00718328?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.